Natural EVs in cancer therapy. a) TEX stimulate immune activation by
Por un escritor de hombre misterioso
Descripción
Download scientific diagram | Natural EVs in cancer therapy. a) TEX stimulate immune activation by boosting T‐cell expansion and function via APCs especially DC cells. DEX activate T cells by mimicking the role of APCs. b) NK‐cell‐derived EVs induce tumor cell death through FasL, perforin, and TNF‐α. c) EVs from M1 macrophages can re‐educate tumor associated macrophages from M2 to M1 phenotype, which further activates anti‐tumor immunity. d) Stem‐cell‐derived EVs inhibit the growth of tumor cells through miRNA‐mediated mechanisms. Abbreviations: DC cell, dendritic cell; DEX, dendritic cell‐derived EVs; FasL, Fas ligand; M1 EVs, M1 macrophage‐derived EVs; MHC, major histocompatibility complex; MSCs, mesenchymal stem cells; NK EVs, NK cell‐derived EVs; TCR, T cell receptor; TEX, tumor cell‐derived EVs; TNF‐α, tumor necrosis factor‐α; TNFR, tumor necrosis factor receptor. from publication: Engineered Extracellular Vesicles for Cancer Therapy | Extracellular vesicles (EVs) have emerged as a novel cell-free strategy for the treatment of many diseases including cancer. As a result of their natural properties to mediate cell-to-cell communication and their high physiochemical stability and biocompatibility, EVs are | Extracellular Vesicles, Cancer Therapy and Bioinspired | ResearchGate, the professional network for scientists.
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Frontiers Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy
Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies: Molecular Therapy - Oncolytics
Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy - ScienceDirect
Frontiers Increasing the Therapeutic Efficacy of Extracellular Vesicles From the Antigen-Specific Antibody and Light Chain Perspective
Cancers, Free Full-Text
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Antiviral CD8+ T-cell immune responses are impaired by cigarette smoke and in COPD
Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy - Xie - 2019 - Advanced Science - Wiley Online Library
Frontiers Extracellular Vesicles: Recent Insights Into the Interaction Between Host and Pathogenic Bacteria
de
por adulto (el precio varía según el tamaño del grupo)